Return
Company Page
KERVALION
Founders
KERVALION is a French MedTech deeptech startup developing 3D-printed, bio-based bone grafts for dental and orthopedic surgery. The company's flagship product is a patient-specific, bioresorbable bone graft designed to address jawbone deficiencies affecting nearly 50% of dental implant cases, enabling single-surgery treatment, faster recovery, and reduced infection risk. Founded on research from CNRS, INSERM, and CHU de Montpellier, KERVALION is backed by BPI France and supported by incubators including SATT AxLR and Montpellier BIC, with ambitions to expand into the broader orthopedic bone graft market.
Company Founded in 2024
Healthtech & Biotech